Altair Nanotechnologies, Inc.
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
____________
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of
Report (date of earliest event reported):
May 9, 2007
Altair
Nanotechnologies Inc.
(Exact Name of Registrant as Specified in its Charter)
Canada
|
|
1-12497
|
|
33-1084375
|
(State
or other jurisdiction of
|
|
(Commission
|
|
(IRS
Employer
|
incorporation
or organization)
|
|
File
Number)
|
|
Identification
No.)
|
|
204
Edison Way
|
|
|
|
|
Reno,
NV
|
|
89502
|
|
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
|
Registrant's
Telephone Number, Including Area Code:
N/A
(Former name, former address, and formal fiscal year, if changed since
last report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see
General
Instruction A.2. below):
[
]
Written communications pursuant to Rule 425 under the Securities Act
(17
CFR
230.425)
[
]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR
240.14a-12)
[
]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[
]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c)
Item
2.02 Results of Operations and Financial Condition.
On
May 9,
2007, Altair Nanotechnologies Inc. (the "Company") issued a press release
entitled “Altair Nantechnologies Reports First Quarter 2007 Financial Results.”
The full text of the press release is provided herewith as Exhibit
99.1.
The
information in Item 2.02 of this Report (including exhibit 99.1) shall not
be
deemed to be "filed" for purposes of Section 18 of the Securities Exchange
Act
of 1934, as amended (the "Exchange Act"), or otherwise subject to the
liabilities of that section, nor shall it be deemed incorporated by reference
in
any filing made by the Company under the Securities Act of 1933, as amended,
or
the Exchange Act, except as expressly set forth by specific reference in such
a
filing.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits.
99.1
Press Release issued by the Company dated May 9, 2007
SIGNATURES
Pursuant
to the requirements of the Securities Exchange of 1934, the registrant has
duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
Altair Nanotechnologies Inc.
Dated:
May
9,
2007
By:
/s/
Edward Dickinson
Edward
Dickinson, Chief Financial Officer